Clinical Trials for Supernus Pharmaceuticals

Use of Gocovri to Improve Disability Due to Radiation Encephalopathy

SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures

Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures

Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD

BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Infusion of Apomorphine: Long-term Safety Study

National Pregnancy Registry for Psychiatric Medications